Daisaikoto improves fatty liver and obesity in melanocortin-4 receptor gene-deficient mice via the activation of brown adipose tissue

[1]  T. Zhu,et al.  Involvement of TRP Channels in Adipocyte Thermogenesis: An Update , 2021, Frontiers in Cell and Developmental Biology.

[2]  W. Ogawa,et al.  Canagliflozin ameliorates hepatic fat deposition in obese diabetic mice: Role of prostaglandin E2. , 2021, Biochemical and biophysical research communications.

[3]  Nina Fujita,et al.  Daisaikoto Prevents Post-dieting Weight Regain by Reversing Dysbiosis and Reducing Serum Corticosterone in Mice , 2019, Front. Physiol..

[4]  M. Manns,et al.  Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. , 2018, Journal of hepatology.

[5]  Kenya Matsumoto,et al.  Daisaikoto Inhibits Pancreatic Lipase Activity and Decreases Serum Triglyceride Levels in Mice. , 2018, Biological & pharmaceutical bulletin.

[6]  I. Căruntu,et al.  Adipocytes spectrum - From homeostasia to obesity and its associated pathology. , 2018, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[7]  Liang-Tzung Lin,et al.  Identification of baicalin from Bofutsushosan and Daisaikoto as a potent inducer of glucose uptake and modulator of insulin signaling-associated pathways , 2018, Journal of food and drug analysis.

[8]  C. Ventura,et al.  Melatonin and Vitamin D Interfere with the Adipogenic Fate of Adipose-Derived Stem Cells , 2017, International journal of molecular sciences.

[9]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[10]  J. Hasegawa,et al.  Effect of Daisaikoto on Expressions of SIRT1 and NF-kappaB of Diabetic Fatty Liver Rats Induced by High-Fat Diet and Streptozotocin , 2016, Yonago acta medica.

[11]  H. Tilg,et al.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. , 2016, Journal of hepatology.

[12]  May-yun Wang,et al.  Pdgfrβ+ Mural Preadipocytes Contribute to Adipocyte Hyperplasia Induced by High-Fat-Diet Feeding and Prolonged Cold Exposure in Adult Mice. , 2016, Cell metabolism.

[13]  T. Saibara,et al.  Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis , 2015, Journal of Gastroenterology.

[14]  M. Lutter,et al.  Regulation of Glucose Tolerance and Sympathetic Activity by MC4R Signaling in the Lateral Hypothalamus , 2015, Diabetes.

[15]  S. Kajimura,et al.  A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis. , 2014, Annual review of physiology.

[16]  U. Eriksson,et al.  Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease , 2013, Nature Protocols.

[17]  Yun-Hee Lee,et al.  In vivo identification of bipotential adipocyte progenitors recruited by β3-adrenoceptor activation and high-fat feeding. , 2012, Cell metabolism.

[18]  S. Terai,et al.  Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. , 2011, The American journal of pathology.

[19]  Jan Nedergaard,et al.  Chronic Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes* , 2009, The Journal of Biological Chemistry.

[20]  T Vrekoussis,et al.  Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB-based model. , 2009, Anticancer research.

[21]  Robert A. McGovern,et al.  Divergence of Melanocortin Pathways in the Control of Food Intake and Energy Expenditure , 2005, Cell.

[22]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[23]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[24]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[25]  H. Bier,et al.  Cisplatin reduces epidermal growth factor receptors in squamous-cell carcinoma in vitro. Preliminary results. , 1990, ORL; journal for oto-rhino-laryngology and its related specialties.

[26]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[27]  European Association for the Study of the Liver,et al.  EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease , 2016, Obesity Facts.

[28]  Cheng-Li Lin,et al.  A population-based cohort study. , 2015 .

[29]  M. Klingenspor,et al.  CALL FOR PAPERS Mitochondrial Function/Dysfunction in Health and Disease Uncoupling protein 1 expression and high-fat diets , 2011 .

[30]  K. Nakao,et al.  A Novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. , 2002, Diabetes.

[31]  K. Johnson.  An Update. , 1984, Journal of food protection.